Cited by 165Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and TreatmentsCardiac pacing and defibrillation studies

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Catheter Ablation of Atrial Fibrillation in Patients with Diabetes Mellitus Type 2: Results from a Randomized Study Comparing Pulmonary Vein Isolation Versus Antiarrhythmic Drug Therapy

FORLEO, GIOVANNI B., MANTICA, MASSIMO, DE LUCA, LUCIA, LEO, ROBERTO, SANTINI, LUCA, PANIGADA, STEFANIA, DE SANCTIS, VALERIO, PAPPALARDO, AUGUSTO, LAURENZI, FRANCESCO, AVELLA, ANDREA, CASELLA, MICHELA, RUSSO, ANTONIO DELLO, ROMEO, FRANCESCO, PELARGONIO, GEMMA, TONDO, CLAUDIO·2009·Journal of Cardiovascular Electrophysiology

DOI 10.1111/j.1540-8167.2008.01275.x

Open this paper in CoChat — free account

Abstract

INTRODUCTION: Atrial fibrillation (AF) and diabetes mellitus type 2 (DM2) often coexist; however, a small number of patients with DM2 undergoing catheter ablation (CA) of AF have been included in previous studies. The aim of this study was to evaluate safety and efficacy of ablation therapy in DM2 patients with drug refractory AF. METHODS AND RESULTS: From January 2005 to September 2006, 70 patients with a diagnosis of DM2 and paroxysmal (n = 29) or persistent (n = 41) AF were randomized to receive either pulmonary vein isolation or a new antiarrhythmic drug treatment (ADT) with a 1-year follow-up. The primary endpoint was the time to first AF recurrence. By Kaplan-Meier analysis, at the end of follow-up, 42.9% of patients in the ADT group and 80% of patients who received a single ablation procedure and were without medications were free of AF (P = 0.001). In the ablation group, a significant improvement in quality-of-life (QoL) scores as compared with ADT group was observed. Six patients in the ADT group (17.1%) developed significant adverse drug effects. Hospitalization rate during follow-up was higher in the ADT group (P = 0.01). The only complication attributable to ablation was one significant access-site hematoma. CONCLUSION: In patients with DM2, CA of AF provides significant clinical benefits over the ADT and appears to be a reasonable approach regarding feasibility, effectiveness, and low procedural risk.

Integrity signals

Registry

Crossref · 10.1111/j.1540-8167.2008.01275.x

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The MOS 36-ltem Short-Form Health Survey (SF-36): III. Tests of Data Quality, Scaling Assumptions, and Reliability Across Diverse Patient Groups
McHorney, C. A., Ware, J. E., Rachel Lu, J. F., & Sherbourne, C. D. (1994) · Medical Care · doi:10.1097/00005650-199401000-00004 · Cited by 4,458
A comparison of rate control and rhythm control in patients with atrial fibrillation
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa021328 · Cited by 4,405
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.177292 · Cited by 2,805
A Comparison of Rate Control and Rhythm Control in Patients with Recurrent Persistent Atrial Fibrillation
Gelder, I. C. V., Hagens, V. E., Bosker, H. A., Kingma, J. H., Otto Kamp, B., Kingma, T., Said, S. A., Darmanata, J. I., Timmermans, A. J. M., Tijssen, J. G. P., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021375 · Cited by 2,355
Epidemiologic Features of Chronic Atrial Fibrillation
Kannel, W. B., Abbott, R. D., Savage, D. D., & McNamara, P. M. (1982) · New England Journal of Medicine · doi:10.1056/nejm198204293061703 · Cited by 2,304
Radiofrequency Ablation vs Antiarrhythmic Drugs as First-line Treatment of Symptomatic Atrial Fibrillation: A Randomized Trial
Wazni, O. M., Marrouche, N. F., Martin, D. O., Verma, A., Bhargava, M., Saliba, W., Bash, D., Schweikert, R., Brachmann, J., Gunther, J., et al. (2005) · JAMA · doi:10.1001/jama.293.21.2634 · Cited by 1,121
Catheter Ablation for Atrial Fibrillation in Congestive Heart Failure
Hsu, L., Jaı̈s, P., Sanders, P., Garrigue, S., Hocini, M., Sacher, F., Takahashi, Y., Rotter, M., Pasquié, J., Scavée, C., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041018 · Cited by 890
A Randomized Trial of Circumferential Pulmonary Vein Ablation Versus Antiarrhythmic Drug Therapy in Paroxysmal Atrial Fibrillation
Pappone, C., Augello, G., Sala, S., Gugliotta, F., Vicedomini, G., Gulletta, S., Paglino, G., Mazzone, P., Sora, N., Greiss, I., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.08.037 · Cited by 685
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation–executive summary
Authors Task Force Members, Fuster, V., Rydén, L., Cannom, D. S., Crijns, H. J. G. M., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Heuzey, J. L., Kay, G. N., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl176 · Cited by 646
Characterization of Different Subsets of Atrial Fibrillation in General Practice in France
Lévy, S., Maarek, M., Coumel, P., Guize, L., Lekieffre, J., Medvedowsky, J. L., & Sebaoun, A. (1999) · Circulation · doi:10.1161/01.cir.99.23.3028 · Cited by 580

Show all 28 references

Sorted by citations

2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström‐Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 10,550
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P. F., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castellà, M., Diener, H., Heidbüchel, H., Hendriks, J., et al. (2016) · EP Europace · doi:10.1093/europace/euw295 · Cited by 6,438
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Joglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A. M., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001193 · Cited by 3,145
2023 ESC guidelines for the management of cardiomyopathies
Arbelo, E., Protonotarios, A., Gimeno, J. R., Arbustini, E., Barriales-Villa, R., Basso, C., Bezzina, C. R., Biagini, E., Blom, N. A., de Boer, R. A., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad194 · Cited by 2,844
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
Calkins, H. G., Hindricks, G., Cappato, R., Kim, Y., Saad, E., Aguinaga, L., Akar, J. G., Badhwar, V., Brugada, J., Camm, A. J., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.05.012 · Cited by 2,794
2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes.
Marx, N., Federici, M., Schütt, K., Müller-Wieland, D., Ajjan, R. A., Antunes, M. J., Christodorescu, R. M., Crawford, C., Di Angelantonio, E., Eliasson, B., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad192 · Cited by 1,642
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezw313 · Cited by 1,403
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
Calkins, H. G., Hindricks, G., Cappato, R., Kim, Y., Saad, E., Aguinaga, L., Akar, J. G., Badhwar, V., Brugada, J., Camm, A. J., et al. (2017) · EP Europace · doi:10.1093/europace/eux274 · Cited by 1,203
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation
Joglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.08.017 · Cited by 933
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary
Calkins, H. G., Hindricks, G., Cappato, R., Kim, Y., Saad, E., Aguinaga, L., Akar, J. G., Badhwar, V., Brugada, J., Camm, A. J., et al. (2017) · Journal of Arrhythmia · doi:10.1016/j.joa.2017.08.001 · Cited by 709
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary
Calkins, H. G., Hindricks, G., Cappato, R., Kim, Y., Saad, E., Aguinaga, L., Akar, J. G., Badhwar, V., Brugada, J., Camm, A. J., et al. (2017) · EP Europace · doi:10.1093/europace/eux275 · Cited by 521
Atrial Fibrillation and Diabetes Mellitus
Wang, A., Green, J. B., Halperin, J. L., & Piccini, J. P. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.07.020 · Cited by 419
Effect of Catheter Ablation vs Antiarrhythmic Medication on Quality of Life in Patients With Atrial Fibrillation
Blomström‐Lundqvist, C., Gizurarson, S., Schwieler, J. H., Jensen, S. M., Bergfeldt, L., Kennebäck, G., Rubulis, A., Malmborg, H., Raatikainen, P. M. J., Lönnerholm, S., et al. (2019) · JAMA · doi:10.1001/jama.2019.0335 · Cited by 363
Catheter Ablation Versus Medical Therapy for Atrial Fibrillation
Asad, Z. U. A., Yousif, A., Khan, M. S., Al‐Khatib, S. M., & Stavrakis, S. (2019) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.119.007414 · Cited by 226
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary
Calkins, H. G., Hindricks, G., Cappato, R., Kim, Y., Saad, E., Aguinaga, L., Akar, J. G., Badhwar, V., Brugada, J., Camm, A. J., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.07.009 · Cited by 226
The Increasing Role of Rhythm Control in Patients With Atrial Fibrillation
Camm, A. J., Naccarelli, G. V., Mittal, S., Crijns, H. J. G. M., Hohnloser, S. H., Ma, C., Natale, A., Turakhia, M. P., & Kirchhof, P. F. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.03.337 · Cited by 217
The State of the Art
Morin, D. P., Bernard, M. L., Madias, C. A., Rogers, P. A., Thihalolipavan, S., & Estes, N. A. M. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.08.022 · Cited by 201
The 4S-AF Scheme (Stroke Risk; Symptoms; Severity of Burden; Substrate): A Novel Approach to In-Depth Characterization (Rather than Classification) of Atrial Fibrillation
Potpara, T., Lip, G. Y. H., Blomström‐Lundqvist, C., Boriani, G., Gelder, I. C. V., Heidbüchel, H., Hindricks, G., & Camm, A. J. (2020) · Thrombosis and Haemostasis · doi:10.1055/s-0040-1716408 · Cited by 185
Rate- and Rhythm-Control Therapies in Patients With Atrial Fibrillation: A Systematic Review
Al-Khatib, S. M., Allen LaPointe, N. M., Chatterjee, R., Crowley, M. J., Dupre, M. E., Kong, D. F., Lopes, R. D., Povsic, T. J., Raju, S. S., Shah, B., et al. (2014) · Annals of Internal Medicine · doi:10.7326/m13-1467 · Cited by 178
Catheter ablation in patients with persistent atrial fibrillation
Kirchhof, P. F., & Calkins, H. G. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw260 · Cited by 156
Guidelines for Non-Pharmacotherapy of Cardiac Arrhythmias (JCS 2011)
JCS Joint Working Group (2012) · Circulation Journal · doi:10.1253/circj.cj-66-0054 · Cited by 149
Rhythm control in atrial fibrillation
Piccini, J. P., & Fauchier, L. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31277-6 · Cited by 147
Approach to the Catheter Ablation Technique of Paroxysmal and Persistent Atrial Fibrillation: A Meta-Analysis of the Randomized Controlled Trials
Parkash, R., Tang, A., Sapp, J. L., & Wells, G. A. (2011) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2011.02010.x · Cited by 137
Atrial fibrillation burden in clinical practice, research, and technology development: a clinical consensus statement of the European Society of Cardiology Council on Stroke and the European Heart Rhythm Association
Doehner, W., Boriani, G., Potpara, T., Blomström‐Lundqvist, C., PASSMAN, R. S., Sposato, L. A., Dobrev, D., Freedman, B., Gelder, I. C. V., Glotzer, T. V., et al. (2025) · EP Europace · doi:10.1093/europace/euaf019 · Cited by 157
Cardiac Arrhythmias in Autoimmune Diseases
Gawalko, M. M., Balsam, P., Lodziński, P., Grabowski, M., Krzowski, B., Opolski, G., & Kosiuk, J. (2020) · Circulation Journal · doi:10.1253/circj.cj-19-0705 · Cited by 134
Type 2 diabetes mellitus and atrial fibrillation: From mechanisms to clinical practice
Tadić, M., & Cuspidi, C. (2015) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2015.01.009 · Cited by 131
Radiofrequency Catheter Ablation and Antiarrhythmic Drug Therapy
Pappone, C., Vicedomini, G., Augello, G., Manguso, F., Saviano, M., Baldi, M., Petretta, A., Giannelli, L., Ćalović, Ž., Guluta, V., et al. (2011) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.111.966408 · Cited by 113
Risk factors for atrial fibrillation recurrence
Vizzardi, E., Curnis, A., Latini, M. G., Salghetti, F., Rocco, E., Lupi, L., Rovetta, R., Quinzani, F., Bonadei, I., Bontempi, L., et al. (2012) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e328358554b · Cited by 113
Drugs vs. ablation for the treatment of atrial fibrillation: the evidence supporting catheter ablation
Nault, I., Miyazaki, S., Forclaz, A., Wright, M. J., Jadidi, A., Jaı̈s, P., Hocini, M., & Haı̈ssaguerre, M. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq079 · Cited by 106
Association Between Pre-Ablation Glycemic Control and Outcomes Among Patients With Diabetes Undergoing Atrial Fibrillation Ablation
Donnellan, E., Aagaard, P., Kanj, M. H., Jaber, W. A., Elshazly, M. B., Hoosien, M., Baranowski, B. J., Hussein, A. A., Saliba, W. I., & Wazni, O. M. (2019) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2019.05.018 · Cited by 105
Impact of SGLT2 Inhibitors on AF Recurrence After Catheter Ablation in Patients With Type 2 Diabetes
Abu-Qaoud, M. R., Kumar, A., Tarun, T., Abraham, S., Ahmad, J., Khadke, S., Husami, R., Kulbak, G., Sahoo, S., Januzzi, J. L., et al. (2023) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2023.06.008 · Cited by 104
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary
Calkins, H. G., Hindricks, G., Cappato, R., Kim, Y., Saad, E., Aguinaga, L., Akar, J. G., Badhwar, V., Brugada, J., Camm, A. J., et al. (2017) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-017-0277-z · Cited by 100
Obesity, Diabetes and Atrial Fibrillation; Epidemiology, Mechanisms and Interventions
Asghar, O., Alam, U., Hayat, S. A., Aghamohammadzadeh, R., Heagerty, A. M., & Malik, R. A. (2012) · Current Cardiology Reviews · doi:10.2174/157340312803760749 · Cited by 94
Catheter Ablation and Antiarrhythmic Drug Therapy as First- or Second-Line Therapy in the Management of Atrial Fibrillation
Khan, A. R., Khan, S., Sheikh, M. A., Khuder, S., Grubb, B. P., & Moukarbel, G. V. (2014) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.114.001853 · Cited by 89
Catheter ablation of atrial fibrillation in patients with diabetes mellitus: a systematic review and meta-analysis
Anselmino, M., Matta, M., D'ascenzo, F., Pappone, C., Santinelli, V., Bunch, T. J., Neumann, T., Schilling, R. J., Hunter, R. J., Noelker, G., et al. (2015) · Europace · doi:10.1093/europace/euv214 · Cited by 88
Efficacy and safety of catheter ablation versus antiarrhythmic drugs for atrial fibrillation: a meta-analysis of randomized trials
Bonanno, C., Paccanaro, M., Vecchia, L. L., OMETTO, R., & Fontanelli, A. (2010) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e328332e926 · Cited by 82
Efficacy and safety of ablation for people with non-paroxysmal atrial fibrillation
Nyong, J., Amit, G., Adler, A. J., Owolabi, O., Perel, P., Prieto‐Merino, D., Lambiase, P. D., Casas, J. P., & Morillo, C. A. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012088.pub2 · Cited by 75
Persistent atrial fibrillation vs paroxysmal atrial fibrillation: differences in management
Margulescu, A. D., & Mont, L. (2017) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2017.1355237 · Cited by 70
Effect of catheter ablation versus antiarrhythmic drugs on atrial fibrillation: A meta-analysis of randomized controlled trials
Shi, L.-Z., HENG, R., Liu, S., & LENG, F.-Y. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2545 · Cited by 56
Radiofrequency Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation
Siontis, K. C., Ioannidis, J. P. A., Katritsis, G., Noseworthy, P. A., Packer, D. L., Hummel, J. D., Jaı̈s, P., Krittayaphong, R., Mont, L., Morillo, C. A., et al. (2015) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2015.10.003 · Cited by 55
The Clinical Benefits and Mortality Reduction Associated With Catheter Ablation in Subjects With Atrial Fibrillation
Khan, S. U., Rahman, H., Talluri, S., & Kaluski, E. (2018) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2018.03.003 · Cited by 53
Atrial fibrillation in patients with diabetes: molecular mechanisms and therapeutic perspectives.
Sensi, F. D., Potter, T. J. R. D., Cresti, A., Severi, S., & BREITHARDT, G. E. (2015) · PubMed Central · doi:10.3978/j.issn.2223-3652.2015.06.03 · Cited by 52
Healthcare Utilization and Expenditures in Patients with Atrial Fibrillation Treated with Catheter Ablation
Ladapo, J. A., David, G., Gunnarsson, C., Hao, S. C., White, S., March, J. L., & Reynolds, M. R. (2011) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2011.02130.x · Cited by 47
Catheter ablation versus medical therapy for patients with persistent atrial fibrillation: a systematic review and meta-analysis of evidence from randomized controlled trials
Chen, C., Zhou, X., Zhu, M., Chen, S., Chen, J., Cai, H., Dai, J. M., Xu, X., & Mao, W. (2018) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-018-0349-8 · Cited by 47
Association of catheter ablation for atrial fibrillation with mortality and stroke: A systematic review and meta-analysis
Barra, S., Baran, J. M., Narayanan, K., Bovéda, S., Fynn, S. P., Heck, P. M., Grace, A. A., Agarwal, S., Primo, J. J., Marijon, É., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.03.068 · Cited by 47
European Heart Rhythm Association (EHRA) position paper on arrhythmia management and device therapies in endocrine disorders, endorsed by Asia Pacific Heart Rhythm Society (APHRS) and Latin American Heart Rhythm Society (LAHRS)
Gorenek, B., Boriani, G., Dan, G.-A., Fauchier, L., Fenelon, G., Huang, H., Kudaiberdieva, G., Lip, G. Y. H., Mahajan, R., Potpara, T., et al. (2018) · EP Europace · doi:10.1093/europace/euy051 · Cited by 43
Diabetes mellitus and atrial fibrillation-from pathophysiology to treatment
Leopoulou, M., Theofilis, P., Kordalis, A., Παπαγεωργίου, Ν., Sagris, Μ., Oikonomou, E. K., & Tousoulis, D. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i5.512 · Cited by 47
Catheter ablation for paroxysmal and persistent atrial fibrillation
Chen, H. S., Wen, J., Wu, S., & Liu, J. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007101.pub2 · Cited by 42
Catheter ablation of atrial fibrillation in patients with diabetes mellitus
Wang, A., Truong, T., Black‐Maier, E., Green, C. L., Campbell, K. B., Barnett, A. S., Febre, J., Loring, Z., Al‐Khatib, S. M., Atwater, B. D., et al. (2020) · Heart Rhythm O2 · doi:10.1016/j.hroo.2020.04.006 · Cited by 41
Smartphone ECG Monitoring System Helps Lower Emergency Room and Clinic Visits in Post–Atrial Fibrillation Ablation Patients
Aljuaid, M., Marashly, Q., Danaf, J. A., Tawhari, I. H., Barakat, M. M., Barakat, R., Zobell, B., Cho, W., Chelu, M. G., & Marrouche, N. F. (2020) · Clinical Medicine Insights Cardiology · doi:10.1177/1179546820901508 · Cited by 40
HbA1c levels as predictors of ablation outcome in type 2 diabetes mellitus and paroxysmal atrial fibrillation
Lu, Z.-H., Liu, N., Bai, R., Yao, Y., Li, S.-N., Yu, R., Sang, C., Tang, R., Long, D., Du, X., et al. (2014) · Herz · doi:10.1007/s00059-014-4154-6 · Cited by 40
Catheter Ablation for Atrial Fibrillation
Thomas, S. P., & Sanders, P. (2012) · Heart Lung and Circulation · doi:10.1016/j.hlc.2012.03.122 · Cited by 38
Data Linking Diabetes Mellitus and Atrial Fibrillation—How Strong Is the Evidence? From Epidemiology and Pathophysiology to Therapeutic Implications
Şerban, R. C., & Scridon, A. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2018.08.018 · Cited by 36
Atrial Fibrillation Ablation and Reduction of Stroke Events
Barra, S., Narayanan, K., Bovéda, S., Primo, J. J., Gonçalves, H., Baran, J. M., Agarwal, S., Marijon, É., & Providencia, R. A. (2019) · Stroke · doi:10.1161/strokeaha.119.026890 · Cited by 33
Efficacy and Safety of Catheter Ablation vs Antiarrhythmic Drugs as Initial Therapy for Management of Symptomatic Paroxysmal Atrial Fibrillation: A Meta-Analysis
Razzack, A. A., Lak, H. M., Pothuru, S., Rahman, S., Hassan, S. A., Hussain, N., Najeeb, H., Reddy, K. T., Syeda, H., Yasmin, F., et al. (2022) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2303112 · Cited by 33
Catheter ablation of atrial fibrillation and atrial flutter in patients with diabetes mellitus: who benefits and who does not? Data from the German ablation registry
Bogossian, H., Frommeyer, G., Brachmann, J., Lewalter, T., Hoffmann, E., Kuck, K. H., Andresen, D., Willems, S., Spitzer, S. G., Deneke, T., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.03.069 · Cited by 32
Cost‐effectiveness of catheter ablation versus medical therapy for the treatment of atrial fibrillation in the United Kingdom
Leung, L. W. M., Imhoff, R. J., Marshall, H. J., Frame, D., Mallow, P. J., Goldstein, L. J., Wei, T., Velleca, M., Taylor, H., & Gallagher, M. M. (2021) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.15317 · Cited by 32
Mechanism of and Therapeutic Strategy for Atrial Fibrillation Associated with Diabetes Mellitus
Lin, Y., Li, H., Lan, X., Chen, X., Zhang, A., & Li, Z. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/209428 · Cited by 32
Novel Perspectives on Arrhythmia-Induced Cardiomyopathy
Rocca, D. G. D., Santini, L., Forleo, G. B., Sanniti, A., Prete, A. D., Lavalle, C., Biase, L. D., Natale, A., & Romeo, F. (2014) · Cardiology in Review · doi:10.1097/crd.0000000000000040 · Cited by 31
Guía ESC 2020 sobre el diagnóstico y tratamiento de la fibrilación auricular, desarrollada en colaboración de la European Association of Cardio-Thoracic Surgery (EACTS)
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström‐Lundqvist, C., Boriani, G., Castellà, M., Dan, G., Dilaveris, P., et al. (2021) · Revista Española de Cardiología · doi:10.1016/j.recesp.2020.10.022 · Cited by 34
Mortality after catheter ablation for atrial fibrillation compared with antiarrhythmic drug therapy. A meta-analysis of randomized trials
Dagres, N., Varounis, C., Flevari, P. G., Piorkowski, C., Bode, K., Rallidis, L. S., Tsougos, E., Leftheriotis, D. I., Sommer, P., Hindricks, G., et al. (2009) · American Heart Journal · doi:10.1016/j.ahj.2009.05.012 · Cited by 26
Mortality benefit of catheter ablation versus medical therapy in atrial fibrillation: An RCT only meta‐analysis
Ravi, V., Poudyal, A., Li, L., Larsen, T. R., Wasserlauf, J., Trohman, R. G., Krishnan, K., Sharma, P. S., & Huang, H. D. (2021) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.15330 · Cited by 25
Cost-Effectiveness of Catheter Ablation for Rhythm Control of Atrial Fibrillation
Blackhouse, G., Assasi, N., Xie, F., Gaebel, K., Campbell, K., Healey, J. S., O’Reilly, D. J., & Goeree, R. A. (2013) · International Journal of Vascular Medicine · doi:10.1155/2013/262809 · Cited by 25
Catheter and Surgical Ablation for Atrial Fibrillation
Montané, B., Zhang, S., Wolfe, J. D., Prime, S., Luo, C., Cooper, D. H., Doering, M. M., Blomström‐Lundqvist, C., Nashef, S. A. M., Osmancik, P. P., et al. (2025) · Annals of Internal Medicine · doi:10.7326/annals-25-00253 · Cited by 24
Effectiveness of catheter ablation of atrial fibrillation in Belgian practice: a cohort analysis on administrative data
Brabandt, H. V., Neyt, M., & Devos, C. (2013) · EP Europace · doi:10.1093/europace/eut004 · Cited by 24
Ablation procedures for rhythm control in patients with atrial fibrillation: clinical and cost-effectiveness analyses.
Assasi, N., Blackhouse, G., Xie, F. X., Gaebel, K., Robertson, D., Hopkins, R. B., Healey, J. S., Roy, D., & Goeree, R. A. (2012) · Europe PMC (PubMed Central) · Cited by 24
Long-Term Outcomes and Improvements in Quality of Life in Patients with Atrial Fibrillation Treated with Catheter Ablation vs. Antiarrhythmic Drugs
Zheng, Z., Fan, J., Ji, C., Cheng, Y., Chen, X., Tang, A.-L., Feng, C., Ma, Y.-D., Hu, X., Jiang, J., et al. (2020) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-020-00435-9 · Cited by 22
Catheter Ablation of Atrial Fibrillation
Tung, R. H., Buch, E. F., & Shivkumar, K. (2012) · Circulation · doi:10.1161/circulationaha.111.048421 · Cited by 22
Prevalence and Influence of Hyperthyroidism on the Long-Term Outcome of Catheter Ablation for Drug-Refractory Atrial Fibrillation
Machino, T., Tada, H., Sekiguchi, Y., Yamasaki, H., Kuroki, K., Igarashi, M., Naruse, Y., Nakano, E., Ito, Y., Kaneshiro, T., et al. (2012) · Circulation Journal · doi:10.1253/circj.cj-12-0340 · Cited by 21
Complication rates of atrial fibrillation ablations: Comparison of safety outcomes from real world to contemporary randomized control trials
Pothineni, N. V. K., Deshmukh, A. J., Pant, S., Patel, N., Badheka, A., Chothani, A., Shah, N. N., Mehta, K. D., Savani, G. T., Singh, V., et al. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.04.250 · Cited by 20
Diabetes and Endocrine Disorders (Hyperthyroidism/Hypothyroidism) as Risk Factors for Atrial Fibrillation
Higa, S., Maesato, A., Ishigaki, S., Suenari, K., Chen, Y., & Chen, S. (2021) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2020.11.005 · Cited by 21
Management and prognosis of atrial fibrillation in the diabetic patient
Pallisgaard, J. L., Lindhardt, T. B., Olesen, J. B., Hansen, M. L., Carlson, N., & Gislason, G. (2015) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2015.1043892 · Cited by 19
Catheter ablation for the treatment of atrial fibrillation is associated with a reduction in health care resource utilization
Samuel, M., Tsadok, M. A., Joza, J. E., Behlouli, H., Verma, A., Essebag, V., & Pilote, L. (2017) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.13225 · Cited by 19
Individualized Ablation Strategy Guided By Live Simultaneous Global Mapping to Treat Persistent Atrial Fibrillation
Shi, R., Norman, M. W., Chen, Z., & Wong, T. (2018) · Future Cardiology · doi:10.2217/fca-2017-0109 · Cited by 19
Population-Based Evaluation of Major Adverse Events After Catheter Ablation for Atrial Fibrillation
Samuel, M., Almohammadi, M., Tsadok, M. A., Joza, J. E., Jackevicius, C. A., Koh, M., Behlouli, H., Verma, A., Pilote, L., & Essebag, V. (2017) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2017.04.010 · Cited by 19
Catheter Ablation Is Established as a Treatment Option for Atrial Fibrillation - Is Catheter Ablation Established as a Treatment Option of Atrial Fibrillation? (Pro) -
Takahashi, A. (2010) · Circulation Journal · doi:10.1253/circj.cj-10-0693 · Cited by 18
Gender and AF: Differences and Disparities
Pothineni, N. V. K., & Vallurupalli, S. (2018) · US Cardiology Review · doi:10.15420/usc.2017:39:1 · Cited by 22
What clinical trials of ablation for atrial fibrillation tell us – and what they do not
Amuthan, R., & Curtis, A. B. (2021) · Heart Rhythm O2 · doi:10.1016/j.hroo.2021.02.001 · Cited by 17
Reflections on the usefulness of today’s atrial fibrillation ablation procedure endpoints and patient-reported outcomes
Blomström‐Lundqvist, C., & Wettervik, V. S. (2021) · EP Europace · doi:10.1093/europace/euab318 · Cited by 17
Atrial Fibrillation in the Elderly: A Review
Hakim, F. A., & Shen, W.-K. (2014) · Future Cardiology · doi:10.2217/fca.14.32 · Cited by 19
A Patient With Asymptomatic Cerebral Lesions During AF Ablation: How Much Should We Worry?
Forleo, G. B., Rocca, D. G. D., Lavalle, C., Mantica, M., Papavasileiou, L. P., Ribatti, V., Panattoni, G., Santini, L., Natale, A., & Biase, L. D. (2016) · PubMed Central · doi:10.4022/jafib.1323 · Cited by 17
Catheter ablation versus anti-arrhythmic drug therapy for the management of a trial fibrillation: a meta-analysis
Cheng, X., Li, X., He, Y., Liu, X., Wang, G., Cheng, L. T., & Hu, J. (2014) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-014-9945-4 · Cited by 14
Antiarrhythmic drug therapy and catheter ablation in patients with paroxysmal or persistent atrial fibrillation: a systematic review and meta-analysis
Chander, S., Kumari, R., Luhana, S., Shiwlani, S., Parkash, O., Sorath, F., Wang, H. Y., Tan, S., Rahaman, Z., Mohammed, Y. N., et al. (2024) · BMC Cardiovascular Disorders · doi:10.1186/s12872-024-03983-z · Cited by 16
The 2010 Update of the ESC Guidelines for the Management of Atrial Fibrillation - What the Changes Will Mean for Clinicians -
Knecht, S., Wilton, S. B., & Haı̈ssaguerre, M. (2010) · Circulation Journal · doi:10.1253/circj.cj-10-1030 · Cited by 14
Long-term stroke rates after catheter ablation or antiarrhythmic drug therapy for atrial fibrillation: a meta-analysis of randomized trials.
Zheng, Y.-R., Chen, Z., Ye, L., & Wang, L. (2015) · Europe PMC (PubMed Central) · doi:10.11909/j.issn.1671-5411.2015.05.012 · Cited by 13
Pulsed Field Ablation of Atrial Fibrillation: A Novel Technology for Safer and Faster Ablation
Carta‐Bergaz, A., Ríos-Muñoz, G. R., Ávila, P., Atienza, F., González-Torrecilla, E., & Arenal, Á. (2024) · Biomedicines · doi:10.3390/biomedicines12102232 · Cited by 12
Outcomes of catheter ablation versus antiarrhythmic therapy in patients with atrial fibrillation: a systematic review and meta-analysis
Deshpande, R., Al‐Khadra, Y., SINGANALLUR, P. M., Botchway, A., & Labedi, M. R. (2022) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-022-01365-z · Cited by 13
Current Ablation Strategies for Persistent and Long-Standing Persistent Atrial Fibrillation
Letsas, Κ. P., Efremidis, M., Charalampous, C. M., Tsikrikas, S., & Sideris, A. (2011) · Cardiology Research and Practice · doi:10.4061/2011/376969 · Cited by 12
Meta-Analysis of Catheter Ablation versus Medical Therapy in Patients with Atrial Fibrillation Without Heart Failure
Lakkireddy, D. (2020) · Journal of Atrial Fibrillation · doi:10.4022/jafib.2266 · Cited by 12
Catheter ablation of atrial fibrillation in elderly and very elderly patients: safety, outcomes, and quality of life
Tabaja, C., Younis, A., Santangeli, P., Madden, R. A., Taigen, T. L., Farwati, M., Hayashi, K., Braghieri, L., Rickard, J., Klein, B. M., et al. (2023) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-023-01659-w · Cited by 11
WITHDRAWN: 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
Calkins, H. G., Hindricks, G., Cappato, R., Kim, Y., Saad, E., Aguinaga, L., Akar, J. G., Badhwar, V., Brugada, J., Camm, A. J., et al. (2017) · Journal of Arrhythmia · doi:10.1016/j.joa.2017.07.001 · Cited by 11
Cardiovascular outcome in type 2 diabetes and atrial fibrillation
Costard‐Jäckle, A., Tschöpe, D., & Meinertz, T. (2018) · Herz · doi:10.1007/s00059-018-4704-4 · Cited by 12
Meta-analysis of medical management versus catheter ablation for atrial fibrillation
Mao, Y., Wang, H., Chen, J., & Huang, P. (2020) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm.2020.03.60 · Cited by 11
Tratamiento ablativo de la fibrilación auricular
Pappone, C., & Santinelli, V. (2012) · Revista Española de Cardiología · doi:10.1016/j.recesp.2011.12.023 · Cited by 10
Symptom Under-Recognition of Atrial Fibrillation Patients in Consideration for Catheter Ablation
Katsumata, Y., Kohsaka, S., Ikemura, N., Ueda, I., Hashimoto, K., Yamashita, T., Miyama, H., Fujisawa, T., Kimura, T., Tanimoto, K., et al. (2020) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2020.10.016 · Cited by 10
Atrial fibrillation: cure or treat?
Forleo, G. B., & Tondo, C. (2009) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944709104495 · Cited by 10
Meta-analysis of the therapeutic effects of various methods for the treatment of chronic atrial fibrillation
Lin, G., Lu, H.-H., Shen, Y., Huang, J., Shi, L., & GUO, Y.-N. (2013) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2013.1158 · Cited by 9
Caution over use of catheter ablation for atrial fibrillation
Brabandt, H. V., Neyt, M., & Devos, C. (2013) · BMJ · doi:10.1136/bmj.f5277 · Cited by 9
Electrophysiological Perspectives on Hybrid Ablation of Atrial Fibrillation.
Syed, F. F., & Oral, H. (2015) · PubMed Central · doi:10.4022/jafib.1290 · Cited by 9

Authors: FORLEO, G. B., MANTICA, M., DE LUCA, L., LEO, R., SANTINI, L., PANIGADA, S., DE SANCTIS, V., PAPPALARDO, A., LAURENZI, F., AVELLA, A., CASELLA, M., RUSSO, A. D., ROMEO, F., PELARGONIO, G., & TONDO, C.
Affiliations: Università Cattolica del Sacro Cuore (IT)
Istituto Clinico Sant'Ambrogio (IT)
University of Rome Tor Vergata (IT)
Corresponding author: TONDO, CLAUDIO
ORCID: FORLEO, GIOVANNI B.
SANTINI, LUCA
CASELLA, MICHELA
RUSSO, ANTONIO DELLO
ROMEO, FRANCESCO
PELARGONIO, GEMMA
TONDO, CLAUDIO
Venue: Journal of Cardiovascular Electrophysiology
Publisher: Wiley
Published: 2008-12-29
Volume: 20
Issue: 1
Pages: 22-28
ISSN: 1045-3873 (ISSN-L)
1540-8167
DOI: 10.1111/j.1540-8167.2008.01275.x
OpenAlex: W2105908026
Cited by: 165
References: 28
Citations by year: 2026: 5 · 2025: 6 · 2024: 6 · 2023: 10 · 2022: 7 · 2021: 8 · 2020: 15 · 2019: 5 · 2018: 12 · 2017: 11 · 2016: 11 · 2015: 11 · 2014: 11 · 2013: 11 · 2012: 14
FWCI: 5.09
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Journal of Cardiovascular Electrophysiology (publishedVersion)
PubMed (publishedVersion)
Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
Università Politecnica delle Marche (Università Politecnica delle Marche) (submittedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
Keywords: atrial fibrillation, type 2 diabetes, catheter ablation, pulmonary vein isolation, antiarrhythmic drugs, drug-refractory atrial fibrillation, atrial fibrillation recurrence, quality of life, adverse drug reactions, hospitalization, access site hematoma
MeSH terms: Anti-Arrhythmia Agents, Atrial Fibrillation, Diabetes Mellitus, Type 2, Female, Heart Conduction System, Humans, Italy, Male, Middle Aged, Pulmonary Veins, Treatment Outcome, Catheter Ablation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Catheter Ablation of Atrial Fibrillation in Patients with Diabetes Mellitus Type 2: Results from a Randomized Study Comparing Pulmonary Vein Isolation Versus Antiarrhythmic Drug Therapy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks